# AI Proteins

Source: https://onco.cc/companies/ai-proteins/  
OnCo record `ai-proteins` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

AI Proteins designs small proteins as possible medicines and lists cancer research programmes that would carry radiation to a target.

## Summary

AI Proteins develops de novo miniproteins, proteins designed from first principles. Its pipeline lists internal oncology programmes described as targeted radiotherapy, with undisclosed targets. The page also lists programmes outside oncology. The oncology entries do not establish clinical benefit, and no specific cancer indication or trial phase is inferred from the pipeline graphic.

## Fields

- Kind: Company
- Last checked: 2026-11-06
- HQ: Boston, MA
- Type: biotech
- Website: https://www.aiproteins.com/

## Notes

- Location is the company's business address in its privacy policy, not a separately verified headquarters designation.

## Sources

- Official pipeline: https://www.aiproteins.com/pipeline
- Official location evidence: https://www.aiproteins.com/legal/privacy-policy
- Elicit AI for Pharma market map: https://elicit.com/ai-for-pharma

## Connected records

- fronts: [Drug Discovery Platforms](https://onco.cc/fronts/drug-discovery/)
- collections: [Elicit AI for Pharma market map](https://onco.cc/collections/elicit-ai-for-pharma/)

---
JSON: https://onco.cc/api/v1/entities/ai-proteins.json